Good Clinical Practice (GCP)
Full course · ICH E6(R3) Principles
Free Lesson Preview
This lesson is part of a complete GCP track — 2 courses, quizzes, a final exam, and a free verifiable credential. The optional $29 PDF certificate is recognized by 18+ trial sponsors.
Start learning for freeAlready enrolled? Sign in
Learn the investigator's obligations to comply with the approved protocol, properly document and report deviations, apply the immediate hazard exception correctly, and execute premature termination or suspension procedures when trials end unexpectedly.
The protocol signature is the most consequential signature an investigator places on any clinical trial document. It is not merely an acknowledgment of receipt. It is not simply confirmation that the investigator has read the pages. When an investigator signs the protocol, that signature constitutes a promise: a promise to conduct the trial according to the approved protocol, in compliance with GCP, and in accordance with applicable regulatory requirements.
This promise matters because the entire architecture of clinical research depends upon it. Participants enroll based on what the protocol says will happen to them. Regulators approve trials based on what the protocol specifies. Sponsors plan their development programs based on the data the protocol is designed to generate. When investigators deviate from the protocol without justification, they undermine the foundation upon which everyone else has relied.
And yet, rigid adherence is not always possible. Medicine is practiced in the real world, where unexpected situations arise. A participant experiences an unanticipated reaction that requires immediate intervention not specified in the protocol. Equipment fails. Supplies run out. Sometimes, circumstances demand action that the protocol did not anticipate.
ICH E6(R3) addresses both dimensions of this reality. Section 2.5 establishes the investigator's compliance obligations while recognizing the narrow exception for immediate hazards. Section 2.6 addresses what happens when a trial ends prematurely, whether terminated by the sponsor, suspended by the investigator, or concluded for other reasons. Together, these sections define what it means to keep the promise embedded in that signature, and how to proceed when keeping that promise becomes impossible.
What you will learn5 objectives
By the end of this lesson, you will be able to:
Progress saves itself — finish reading and this lesson completes
